Business Wire

Trilliant’s Corporate Commitment to Sustainability Reinforced with Certifications, Awards

28.8.2023 02:00:00 EEST | Business Wire | Press release

Share

Trilliant, a leading international provider of solutions for advanced metering infrastructure (AMI), smart grid, smart cities and IIoT, continues to focus on its commitment to sustainability for its customers and the company with new recertifications, awards and assessments.

Trilliant previously announced its Integrated Management System was recertified to ISO 9001:2015 and ISO 14001:2015. Recently, DEKRA Audits has also recertified Trilliant in the following areas, solidifying Trilliant’s commitment to sustainable business operations:

  • ISO 27001:2013 standard for information security management systems (ISMS): ISO 27001 is the world's best-known standard for ISMS and defines requirements an ISMS must meet. The standard provides companies with guidance for establishing, implementing, maintaining, and continually improving an information security management system. Conformity with ISO/IEC 27001 means that an organization or business has put in place a system to manage risks related to the security of data owned or handled by the company, and that this system respects all the best practices and principles enshrined in this International Standard.
  • ISO 45001:2018 standard for occupational health and safety (OH&S) management: ISO 45001:2018 specifies requirements for an OH&S management system. It gives guidance for its use to enable organizations to provide safe and healthy workplaces by preventing work-related injury and ill health, as well as by proactively improving its OH&S performance.

In June 2023, Trilliant was recertified for the ECORESPONSIBLE™ Certification, progressing to Level #2 (Performance). This certification in sustainable development management is part of an ongoing four-level improvement process, designed to help organizations improve their overall performance in economic, environmental, social and governance terms. By making strategic decisions regarding sustainable development through their ECORESPONSIBLE practices, organizations show their tangible contribution to sustainable development. In doing so, they reduce their ecological impact and improve their value chain.

Trilliant is also the recipient of a 2022 EcoVadis Silver medal and placed in the top 19 percent within its industry. EcoVadis has grown to become the world’s largest and most trusted provider of business sustainability ratings, creating a global network of more than 100,000+ rated companies. EcoVadis medals recognize companies that have completed the EcoVadis assessment process and demonstrated a relatively strong management system that addresses sustainability criteria, as outlined in the EcoVadis methodology. Companies must also meet specific licensing and eligibility criteria.

Trilliant’s office in Granby, Québec, was recently recognized by the City of Granby with an Environmental Recognition Award. This awards honors citizens, non-profit organizations, businesses, industries and educational institutions of the City of Granby who have made an outstanding contribution to the community and its reputation through their commitment and achievements in environmental and sustainable development matters. Trilliant was honored in the Sustainable Industry category for its ECORESPONSIBLE™ certification.

Sustainability: A key pillar of Trilliant’s strategy

Trilliant understands that not only is sustainability important for future generations, but that utilities and cities want to know their vendors and suppliers are dedicated to social responsibility. To demonstrate its commitment, Trilliant is a participating member of the UN Global Compact. The compact is a global call to action for companies to support the UN’s social development goals (SDGs). Trilliant is focused on four of those goals, which continue to guide the company’s strategy and align with its mission: affordable and clean energy; sustainable cities and communities; responsible consumption and production; and climate action.

“Our commitment to sustainability in our work has never been clearer,” said Andy White, Chairman and CEO, Trilliant. “Our certifications and awards enable Trilliant to be accountable and ensure that our goals and practices have a positive impact on our customers, partners and all our stakeholders. We’re also proud of our global team members who are energized to engage on initiatives that are aligned with the UN SDGs.”

As the company looks ahead, it has engaged COESIO — third-party sustainability experts — to finalize and support the implementation of Trilliant's Net Zero plan. Trilliant will share its progress and impact in a future update.

About Trilliant

Trilliant® empowers the global energy industry with the only device-agnostic communications platform that enables utilities and cities to deploy any application securely and reliably on one powerful network. Our purpose-built portfolio is designed to offer the power of choice, without risk of customers being “locked in” with one technology provider or meter manufacturer. We are proud to offer mission-critical solutions that support AMI, Data & Analytics, Smart Metering, Smart Grids and Smart Cities. Customers worldwide benefit from Trilliant’s unique combination of flexibility, sustainability and scalability that connects utilities and cities to the IIoT and a more strategic path to the Energy Transition. Visit us at www.trilliant.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Tracey Mitchell
tracey.mitchell@trilliant.com

Cindy Watson/Anita Wong
StrategicAmpersand
TrilliantPR@stratamp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FPT Named an OpenAI Select Partner6.8.2026 03:00:00 EEST | Press release

Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 01:10:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of ORZEYFUL marks a new chapter for the narcolepsy type 1 community, as we introduce an entirely new class of medicine that will potentially redefine how this disease is managed and howpeople feel on treatment,” said Julie Kim, president and chief executive officer of Takeda. “We are proud to have discovered and developed this orexin treatment innovation and will bring it to adults living with NT1 as quickly as possible.” NT1 is a rare, chronic neurological disease d

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 23:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 17:05:00 EEST | Press release

Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership, and operational excellence with a track record of execution from first-in-human studies through regulatory

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 17:00:00 EEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye